English | Español
Patient Daily | Mar 17, 2026

J&J and AbbVie CEOs receive pay increases exceeding $30 million in 2025
Patient Daily | Mar 17, 2026

BridgeBio reports positive Phase 3 results for limb-girdle muscular dystrophy drug
Patient Daily | Mar 17, 2026

Eli Lilly warns of safety risks in compounded tirzepatide formulations
Patient Daily | Mar 17, 2026

Biogen, Sarepta, and Edgewise present new data at Muscular Dystrophy Association 2026 conference
Patient Daily | Mar 17, 2026

Los Angeles aims to become a leading global life sciences hub
Patient Daily | Mar 17, 2026

Industry questions FDA’s data-sharing guidance for cell and gene therapy sector
Patient Daily | Mar 17, 2026

Biopharma job postings rise in February, marking first annual increase since 2022
Patient Daily | Mar 17, 2026

Lurie Autism Institute names Huda Zoghbi as first recipient of autism research prize

Trending
+ Regulatory
B. D. Benavides | Mar 18, 2026

Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Five therapies show progress in multiple myeloma treatment landscape
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

FDA biologics director Vinay Prasad to depart in April, analysts predict impact on biotech